PSP Pharma
PSP Pharma, also known as PSP Pharmaceuticals, is a prominent player in the pharmaceutical industry, headquartered in Georgia (GE). Founded in 2005, the company has established itself as a leader in the development and distribution of innovative healthcare solutions across the region, with a strong presence in Eastern Europe and Central Asia. Specialising in a diverse range of therapeutic areas, PSP Pharma offers unique products that cater to the evolving needs of healthcare professionals and patients alike. Their commitment to quality and innovation has earned them a reputable market position, marked by significant milestones in research and development. With a focus on enhancing patient outcomes, PSP Pharma continues to expand its portfolio, delivering high-quality pharmaceuticals that stand out for their efficacy and safety. The company’s dedication to excellence has solidified its status as a trusted partner in the healthcare sector.
DitchCarbon Score
How does PSP Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PSP Pharma's score of 31 is higher than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PSP Pharma's reported carbon emissions
In 2024, PSP Pharma reported total carbon emissions of approximately 8,829,860 kg CO2e, comprising about 8,829,860 kg CO2e from Scope 1 and about 5,694,420 kg CO2e from Scope 2 emissions. This marks an increase from 2023, where total emissions were about 8,363,480 kg CO2e, with Scope 1 emissions at approximately 5,371,320 kg CO2e and Scope 2 emissions at about 2,992,160 kg CO2e. In 2022, the company recorded total emissions of about 10,362,920 kg CO2e, with Scope 1 at approximately 4,587,780 kg CO2e and Scope 2 at about 5,775,140 kg CO2e. Despite the fluctuations in emissions, PSP Pharma has not publicly disclosed specific reduction targets or initiatives as part of their climate commitments. The absence of defined reduction targets suggests a need for further strategic planning in their sustainability efforts. The company continues to monitor and report its emissions, indicating a commitment to transparency in its environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 4,587,780 | 0,000,000 | 0,000,000 |
| Scope 2 | 5,775,140 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PSP Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
